Eli Lilly and Company
METHODS OF TREATING ULCERATIVE COLITIS
Last updated:
Abstract:
The present invention generally relates to the treatment of ulcerative colitis with an anti-IL-23p19 antibody, in particular dosage regimens for the treatment of the disease.
Status:
Application
Type:
Utility
Filling date:
28 Mar 2019
Issue date:
4 Feb 2021